@Artvandelay01Yes, it should be considered. I was noting the...

@Artvandelay01

Yes, it should be considered. I was noting the very different context. Also, look to the John Laing firesale for an example of what's happening across the market.I consider IFN a world-class small-medium outfit with a bright future, with much to credit to the departing Paul Simshauser.

However, we aren't comparing this offering with the sale of Tilt, instead a low management asset that was only expected to fetch, at best, $800m.You will find many investors selecting the security of a long-term PPA arrangement with a credible counterparty. Palisade can run its numbers to 2035, with precision.

IFN's C&I contract length, in comparison, sits at 2-7 years. Investors will be wary of clients activating load flexibility clauses due to COVID soft demand/output, often up to 20%, or declaring Force Majeure. Infigen currently generates ~52% on C&I contracts with expiration retracting this figure to 17% by 2024. There are also several market rules on the horizon which are likely to cause headaches.

The buyer is well positioned, which is why you may not choose to sell. Either way, I'm happy that overnight you've all seen some restoration of value in difficult economic times. I hope to see it hit $1.50.